July 2018: managing herbal-drug interactions - a podcast by BMJ Group

In July’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the risk of drug interactions with herbal medicines.
Read the editorial: https://dtb.bmj.com/content/56/7/73.

The editors also review the evidence for ocrelizumab for relapsing MS and early primary progressive MS (https://dtb.bmj.com/content/56/7/80), and discuss the role of metformin in people with type 1 diabetes (https://dtb.bmj.com/content/56/7/78).

Further episodes of DTB podcast

Further podcasts by BMJ Group

Website of BMJ Group